{
    "clinical_study": {
        "@rank": "16557", 
        "arm_group": [
            {
                "arm_group_label": "Stenfilcon A", 
                "arm_group_type": "Experimental", 
                "description": "Stenfilcon A"
            }, 
            {
                "arm_group_label": "Filcon II 3", 
                "arm_group_type": "Active Comparator", 
                "description": "Filcon II 3"
            }
        ], 
        "brief_summary": {
            "textblock": "Clinical Performance of Stenfilcon vs. Filcon II 3"
        }, 
        "brief_title": "Clinical Performance of Stenfilcon A Versus Filcon II 3", 
        "completion_date": {
            "#text": "May 2013", 
            "@type": "Actual"
        }, 
        "condition": "Myopia", 
        "condition_browse": {
            "mesh_term": "Myopia"
        }, 
        "detailed_description": {
            "textblock": "The objective of this study is to compare the comfort and clinical performance of Stenfilcon\n      vs. Filcon II 3 compared to subject's habitual contact lenses. The null hypothesis is that\n      there is no difference in the clinical performance between the two sets of lenses."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Subjects must satisfy the following conditions prior to inclusion in the study:\n\n          -  Based on his/her knowledge, must be in good general health. Be of legal age (18\n             years) or older.\n\n          -  Be able and willing to adhere to the instructions set forth in this protocol and\n             complete all specified evaluation.\n\n          -  Read, indicate understanding of, and sign Written Informed Consent (Appendix 1)\n\n          -  Require a contact lens prescription between -0.50 and -6.00 and have no more than\n             -.75D of astigmatism in both eyes\n\n          -  Achieve visual acuity of 6/9 or better in each eye with a spherical contact lens\n             prescription.\n\n          -  An existing soft contact lens wearer of any modality.\n\n          -  Must be able to wear their lenses at least 6 full days over the 7 days; 14 hours per\n             day, assuming there are no contraindications for doing so.\n\n          -  Have normal eyes with no evidence of abnormality or disease.  For the purposes of\n             this study a normal eye is defined as one having:\n\n          -  No amblyopia.\n\n          -  No evidence of lid abnormality or infection (e.g. entropion, ectropion, chalazia,\n             recurrent styes).\n\n          -  No clinically significant slit lamp findings (e.g. infiltrates or other slit lamp\n             findings greater than Grade 2: corneal edema, tarsal abnormalities, and conjunctival\n             injection).\n\n          -  No other active ocular disease (e.g. glaucoma, history of recurrent corneal erosions,\n             cornea [infiltrates], conjunctiva, lids, and intraocular infection or inflammation of\n             an allergic, bacterial, or viral etiology.)\n\n          -  No aphakia\n\n        Exclusion Criteria:\n\n        Any of the following will render a subject ineligible for inclusion:\n\n          -  Neophytes, who have not worn lenses before\n\n          -  Greater than 0.75D of refractive astigmatism in either eye\n\n          -  Presence of clinically significant (grade 3 or above) anterior segment abnormalities;\n             inflammations such as iritis; or any infection of the eye, lids, or associated\n             structures.\n\n          -  Presence of ocular or systemic disease or need of medication which might interfere\n             with contact lens wear.\n\n          -  Slit lamp findings that would contraindicate contact lens wear such as:\n\n          -  Pathological dry eye or associated findings\n\n          -  Pterygium, pinguecula or corneal scars within the visual axis\n\n          -  Neovascularization > 0.75 mm in from the limbus\n\n          -  Giant papillary conjunctivitis (GPC) Grade 3 or above\n\n          -  Anterior uveitis or iritis (past or present)\n\n          -  Seborrheic eczema, seborrheic conjunctivitis\n\n          -  History of corneal ulcer or fungal infections\n\n          -  Poor personal hygiene\n\n          -  A known history of corneal hypoesthesia (reduced corneal sensitivity).\n\n          -  Contact lens best corrected Snellen visual acuities (VA) worse than 6/9\n\n          -  Aphakia, Keratoconus or a highly irregular cornea"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "February 14, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01808209", 
            "org_study_id": "EX-MKTG-40"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Stenfilcon A", 
                    "Filcon II 3"
                ], 
                "description": "Filcon II 3", 
                "intervention_name": "Filcon II 3", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": [
                    "Stenfilcon A", 
                    "Filcon II 3"
                ], 
                "description": "Stenfilcon A", 
                "intervention_name": "Stenfilcon A", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 4, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Birmingham", 
                    "country": "United Kingdom", 
                    "state": "West Midlands", 
                    "zip": "B4 7ET"
                }, 
                "name": "University of Aston"
            }
        }, 
        "location_countries": {
            "country": "United Kingdom"
        }, 
        "number_of_arms": "2", 
        "official_title": "Clinical Performance of Stenfilcon A Versus Filcon II 3", 
        "overall_official": {
            "affiliation": "University of Aston Birmingham, West Midlands, United Kingdom", 
            "last_name": "James Wolffsohn, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United Kingdom: Research Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "April 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Handling experience at each visit will be rated on a scale from 0 to 100: 0=impossible and 100=extremely easy.", 
            "measure": "Lens handling", 
            "safety_issue": "No", 
            "time_frame": "after one week of lens wear"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01808209"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Coopervision, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Coopervision, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Single Blind (Investigator)", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}